Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Arthur J. Gallagher & Co
AJG
$65B
| $6.48M | ﹤0.01% |
33,905
-2,653
| -7% | -$503K |
|
802
Watsco Inc
WSO
$12.8B
| $6.48M | ﹤0.01% |
20,370
+8,691
| +74% | +$2.55M |
|
803
Repligen
RGEN
$9.21B
| $6.47M | ﹤0.01% |
38,447
+34,834
| +964% | +$6.22M |
|
|
BERY
804
DELISTED
Berry Global Group, Inc.
BERY
| $6.47M | ﹤0.01% |
119,593
+80,094
| +203% | +$4.43M |
|
|
HOLX
805
DELISTED
Hologic
HOLX
| $6.43M | ﹤0.01% |
79,653
+41,813
| +110% | +$3.37M |
|
806
Agilent Technologies
A
$42B
| $6.36M | ﹤0.01% |
46,007
-133,523
| -74% | -$19.5M |
|
807
TransDigm Group
TDG
$68.4B
| $6.34M | ﹤0.01% |
8,603
+1,616
| +23% | +$1.15M |
|
808
Coca-Cola Europacific Partners
CCEP
$47.2B
| $6.29M | ﹤0.01% |
106,236
+39,940
| +60% | +$2.23M |
|
809
New York Times
NYT
$10.4B
| $6.27M | ﹤0.01% |
161,234
+95,369
| +145% | +$3.51M |
|
810
CenterPoint Energy
CNP
$26.6B
| $6.22M | ﹤0.01% |
211,135
+7,604
| +4% | +$222K |
|
|
NUVL
811
DELISTED
Nuvalent
NUVL
| $6.22M | ﹤0.01% |
237,954
-5,461
| -2% | -$162K |
|
812
Omnicom Group
OMC
$23.2B
| $6.12M | ﹤0.01% |
64,835
-7,916
| -11% | -$701K |
|
813
Ecolab
ECL
$78.7B
| $6.11M | ﹤0.01% |
36,907
-20,931
| -36% | -$3.26M |
|
|
LITT
814
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $6.09M | ﹤0.01% |
600,000
-218
| -0% | -$2.2K |
|
815
Northrop Grumman
NOC
$81.5B
| $6.09M | ﹤0.01% |
13,198
-2,084
| -14% | -$967K |
|
816
Raymond James Financial
RJF
$34.6B
| $6.08M | ﹤0.01% |
65,224
+37,087
| +132% | +$3.93M |
|
817
Manulife Financial
MFC
$72.9B
| $6.07M | ﹤0.01% |
330,985
-241,096
| -42% | -$4.59M |
|
818
Berkshire Hathaway Class A
BRK.A
$1.09T
| $6.06M | ﹤0.01% |
13
-2
| -13% | -$934K |
|
819
Canadian Imperial Bank of Commerce
CM
$110B
| $6.04M | ﹤0.01% |
142,676
-26,396
| -16% | -$1.16M |
|
820
Axcelis
ACLS
$4.33B
| $6.04M | ﹤0.01% |
45,311
+5,036
| +13% | +$592K |
|
821
P3 Health Partners
PIII
$39.1M
| $6.02M | ﹤0.01% |
113,634
-18,824
| -14% | -$1.13M |
|
822
Keurig Dr Pepper
KDP
$39.7B
| $5.99M | ﹤0.01% |
169,783
-98,910
| -37% | -$3.48M |
|
823
Amkor Technology
AMKR
$14.1B
| $5.98M | ﹤0.01% |
229,931
+14,468
| +7% | +$396K |
|
824
Five Below
FIVE
$13B
| $5.97M | ﹤0.01% |
28,967
+12,548
| +76% | +$2.47M |
|
825
DuPont de Nemours
DD
$19.4B
| $5.94M | ﹤0.01% |
65,945
-18,485
| -22% | -$1.69M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.